The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: Why the quest for meaningful prophylaxis still matters-Reference-Cited by-同舟云学术

The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: Why the quest for meaningful prophylaxis still matters

Published:2017-05 Issue:3 Volume:31 Page:173-183
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Chan Shawna T.,Logan Aaron C.^ORCID

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference120 articles.

1. Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR; comparison with recipients of solid organ transplants;Panagou;Transpl Infect Dis,2016

2. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation;Broers;Blood,2000

3. CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT;Schmidt-Hieber;Blood,2013

4. Are we there yet? Impact of the first international standard for cytomegalovirus DNA on the harmonization of results reported on plasma samples;Preiksaitis;Clin Infect Dis,2016

5. Definitions of cytomegalovirus infection and disease in transplant recipients;Ljungman;Clin Infect Dis,2002

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of recurrent cytomegalovirus reactivations post allogenic stem cell transplantation in a population with high seropositivity;Virology Journal;2024-07-02

2. Reactivation of cytomegalovirus and bloodstream infection and its impact on early survival after allogeneic haematopoietic stem cell transplantation: a multicentre retrospective study;Frontiers in Microbiology;2024-06-19

3. Prior cytomegalovirus reactivation may lead to worse bacterial bloodstream infection outcomes in HSCT patients;Transplant Immunology;2024-06

4. Advances in pharmacotherapies for cytomegalovirus infection: what is the current state of play?;Expert Opinion on Pharmacotherapy;2024-04-12

5. Significance of Cytomegalovirus gB Genotypes in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation: Insights from a Single-Centre Investigation;Pharmaceuticals;2024-03-27